Pharmacokinetics of tramadol and its three main metabolites in healthy male and female volunteers
β Scribed by Yalda H. Ardakani; Mohammad-Reza Rouini
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 173 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.584
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics and tolerability of a new putative non-benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An open dose-escalation design was used to study doses from 0.2 to 50 mg in 18 healthy male volunteers. In the second study doses from 50 to 150 mg
The single-and multiple-dose pharmacokinetics and dose-proportionality of oral dolasetron and its active metabolites over the therapeutic dose range was investigated in 18 healthy men. In an open-label, randomized, complete three-way crossover design, each subject received three separate doses: 50,
The pharmacokinetics of diltiazem were studied in seven patients with chronic renal failure (CRF) not requiring dialysis and in three healthy volunteers after a rapid i.v. infusion of 20mg. Mean plasma concentrations at the end of infusion were 3.15 times higher in patients with CRF than in healthy